| LncRNA GAS8-AS1 dinucleotide genetic variant[n.713A>G, n.714T>C] is associated with early-stage disease, lymph node, and distant metastasis in differentiated thyroid cancer. | LncRNA GAS8-AS1 dinucleotide genetic variant(n.713A>G, n.714T>C) is associated with early-stage disease, lymph node, and distant metastasis in differentiated thyroid cancer.
Murugan AK, Al-Hindi H, Alzahrani AS. | 08/12/2024 |
| LncRNA GAS8-AS1 is a Novel Prognostic and Diagnostic Biomarker for Pancreatic Cancer. | LncRNA GAS8-AS1 is a Novel Prognostic and Diagnostic Biomarker for Pancreatic Cancer.
Li Z, Yue G, Li M, Yang D, Yue C, Hu W, Lu H. | 06/18/2022 |
| Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases. | Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases.
Li G, Zhang T, Huang K, Zhu Y, Xu K, Gu J, Huang S, Gu C, Zhan R, Shen J. | 07/31/2021 |
| lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance. | lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
Zhou DL, Liu Q, Xu BH, Li Y, Su X, Ye ZL, Zhang X, Peng JL, Deng L, Tang T, Shao Q, Ma JJ, Yang XH, He CY. | 06/26/2021 |
| lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion. | lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion.
Zha Z, Han Q, Liu W, Huo S., Free PMC Article | 11/28/2020 |
| Expression analysis of growth arrest specific 8 and its anti-sense in breast cancer tissues. | Expression analysis of growth arrest specific 8 and its anti-sense in breast cancer tissues.
Dashti S, Taherian-Esfahani Z, Kholghi-Oskooei V, Ghafouri-Fard S, Taheri M. | 10/31/2020 |
| The current study shows significance of GAS8 and GAS8-AS1 in the pathogenesis of MS and the putative role of GAS8-AS1 as a diagnostic biomarker in a subset of patients. | GAS8 and its naturally occurring antisense RNA as biomarkers in multiple sclerosis.
Patoughi M, Ghafouri-Fard S, Arsang-Jang S, Taheri M. | 02/1/2020 |
| LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis. | LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N, Yin D, Lun B, Guo X., Free PMC Article | 08/3/2019 |
| GAS8-AS1 was downregulated in colorectal cancer (CRC), and its overexpression may inhibit the proliferation of CRC cells by downregulating oncogenic lncRNA AFAP1-AS1. | LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1.
Zhao Y, Chu Y, Sun J, Song R, Li Y, Xu F. | 07/27/2019 |
| Expression of GAS8-AS1 or GAS8 is significantly decreased in hepatocellular carcinoma tissues and is associated with a poor prognosis among hepatocellular carcinoma patients. | The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8.
Pan W, Zhang N, Liu W, Liu J, Zhou L, Liu Y, Yang M., Free PMC Article | 06/1/2019 |
| Mutation in GAS8-AS1 gene is associated with papillary thyroid carcinoma. | Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.
Pan W, Zhou L, Ge M, Zhang B, Yang X, Xiong X, Fu G, Zhang J, Nie X, Li H, Tang X, Wei J, Shao M, Zheng J, Yuan Q, Tan W, Wu C, Yang M, Lin D. | 08/19/2017 |